Kolexia
Joly Florence Oncologie médicale
Joly Florence
Oncologie médicale
Hôpital Côte de Nacre
Caen, France
638 Activités
33 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de l'ovaire Carcinomes Tumeurs de la prostate Tumeurs du sein Carcinome épithélial de l'ovaire Néphrocarcinome Fatigue Récidive tumorale locale Métastase tumorale

Collaborateurs

Voir plus
Gravis-Mescam Gwenaelle
Gravis-Mescam Gwenaelle
Centre Paoli-Calmettes, Marseille, France
Ray Isabelle
Ray Isabelle
Centre Léon-Bérard, Lyon, France
Oudard Stephane
Oudard Stephane
Hôpital Européen Georges Pompidou, Paris, France
Coquan Elodie
Coquan Elodie
Centre François-Baclesse, Caen, France

Industries

Voir plus
Ipsen
30 collaboration(s)
Dernière en 2023
GSK
30 collaboration(s)
Dernière en 2023
MSD
20 collaboration(s)
Dernière en 2022
CanceroDigest
19 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
BISCAY: An Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Multi-Centre, Multi-arm Phase 1b Study in Patients With Muscle Invasive Bladder Cancer (MIBC) Who Have Progressed on Prior Treatment (BISCAY).
Essai Clinique (AstraZeneca)   11 mars 2024
BEATcc: A Randomized Phase III Trial of Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab Versus Platinum Chemotherapy Plus Paclitaxel and Bevacizumab in Metastatic (Stage IVB), Persistent, or Recurrent Carcinoma of the Cervix
Essai Clinique (Grupo Español de Investigación en Cáncer de Ovario)   04 mars 2024
Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC): A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC)
Essai Clinique (Roche)   01 mars 2024
DOMENICA: Randomized Phase III Trial in MMR Deficient Endometrial Cancer Patients Comparing Chemotherapy Alone Versus Dostarlimab in First Line Advanced/Metastatic Setting
Essai Clinique (GSK)   28 février 2024
Carboplatin in metastatic castration-resistant prostate cancer patients with molecular alterations of the DNA damage repair pathway: the PRO-CARBO phase II trial.
Therapeutic advances in urology   28 février 2024
Hidden in plain sight - Survival consequences of baseline symptom burden in women with recurrent ovarian cancer.
Gynecologic oncology   26 février 2024
STARTER: A National, Multicenter, Phase III Randomized Controlled Trial to Assess the Impact of a One-year Supervised Physical Activity Program to Reduce Long-term Cancer-related Fatigue in Metastatic Testicular Germ Cell Tumor Patients
Essai Clinique (Centre Léon-Bérard)   20 février 2024
VICTORIA: A Multicentric, Randomized, Non Comparative, Open-label Phase I/II Evaluating AZD2014 (Dual Mammalian Target of Rapamycin Complex 1/2 (mTORC1/mTORC2) Inhibitor) in Combination With Anastrozole Versus Anastrozole Alone in the Treatment of Metastatic Hormone Receptor-positive Endometrial Adenocarcinoma
Essai Clinique (Centre Léon-Bérard)   12 février 2024
Investigating sexual health after breast cancer by longitudinal assessment of patient-reported outcomes.
ESMO open   12 février 2024
COG-IMMUNO: Study of the Cognition of Patients Treated With
Essai Clinique (Centre François-Baclesse)   08 février 2024